OQS
MDGL icon

Occudo Quantitative Strategies’s Madrigal Pharmaceuticals MDGL Stock Holding History

Occudo Quantitative Strategies’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,719
Closed -$397K – 1038
2023
Q3 		$397K Buy
+2,719
New +$512K 0.05% 570
2022
Q4 		– Sell
-5,789
Closed -$376K – 1208
2022
Q3 		$376K Buy
5,789
+2,444
+73% +$170K 0.03% 768
2022
Q2 		$239K Buy
+3,345
New +$246K 0.02% 857
2021
Q4 		– Sell
-4,564
Closed -$364K – 1175
2021
Q3 		$364K Sell
4,564
-6,914
-60% -$597K 0.04% 662
2021
Q2 		$1.12M Buy
11,478
+3,943
+52% +$467K 0.17% 185
2021
Q1 		$881K Sell
7,535
-3,053
-29% -$356K 0.19% 157
2020
Q4 		$1.18M Buy
+10,588
New +$1.29M 0.37% 43

Other funds holding MDGL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return